These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 16955243)
61. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513 [TBL] [Abstract][Full Text] [Related]
62. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy. DuBuske L Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729 [TBL] [Abstract][Full Text] [Related]
63. The new antihistamines--desloratadine and levocetirizine: a review. Scheinfeld N J Drugs Dermatol; 2002 Dec; 1(3):311-6. PubMed ID: 12851991 [No Abstract] [Full Text] [Related]
64. Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile. Cranswick N; Turzíkova J; Fuchs M; Hulhoven R Int J Clin Pharmacol Ther; 2005 Apr; 43(4):172-7. PubMed ID: 15966463 [TBL] [Abstract][Full Text] [Related]
65. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years. Simons FE; Simons KJ J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790 [TBL] [Abstract][Full Text] [Related]
66. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Paradiso MT; Ferrannini A Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373 [TBL] [Abstract][Full Text] [Related]
67. Central nervous system effects of H1-receptor antagonists in the elderly. Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518 [TBL] [Abstract][Full Text] [Related]
68. Modification of antihistaminic activity of cetirizine by nimesulide. Rewari S; Gupta U J Assoc Physicians India; 1999 Apr; 47(4):389-92. PubMed ID: 10778521 [TBL] [Abstract][Full Text] [Related]
69. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Hindmarch I; Johnson S; Meadows R; Kirkpatrick T; Shamsi Z Curr Med Res Opin; 2001; 17(4):241-55. PubMed ID: 11922397 [TBL] [Abstract][Full Text] [Related]
70. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Molimard M; Diquet B; Benedetti MS Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146 [TBL] [Abstract][Full Text] [Related]
71. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Shedden A Clin Ther; 2006 Jan; 28(1):146-7; author reply 147-9. PubMed ID: 16490589 [No Abstract] [Full Text] [Related]
72. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers. Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449 [TBL] [Abstract][Full Text] [Related]
73. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults. Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125 [TBL] [Abstract][Full Text] [Related]
74. Wheal and flare reactions in skin prick tests of patients treated with montelukast alone or in combination with antihistamines. Ciebiada MG; Barylski M; Ciebiada M Inflamm Res; 2014 Mar; 63(3):191-5. PubMed ID: 24281730 [TBL] [Abstract][Full Text] [Related]
75. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients. Augustin M; Ehrle S J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819 [TBL] [Abstract][Full Text] [Related]
76. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial. Tzanetos DB; Fahrenholz JM; Scott T; Buchholz K Ann Allergy Asthma Immunol; 2011 Dec; 107(6):517-22. PubMed ID: 22123381 [TBL] [Abstract][Full Text] [Related]
77. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects. Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP Allergy; 2000 Apr; 55(4):382-5. PubMed ID: 10782524 [TBL] [Abstract][Full Text] [Related]
78. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Takahashi H; Zhang Y; Morita E Arch Dermatol Res; 2008 Jul; 300(6):291-5. PubMed ID: 18305947 [TBL] [Abstract][Full Text] [Related]
79. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies. Leroy T; van Neste D Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364 [TBL] [Abstract][Full Text] [Related]
80. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]